About Reach Neuro
Reach Neuro is a company based in Pittsburgh (United States) founded in 2018. Reach Neuro has raised $880 thousand across 2 funding rounds from investors including IndieBio. Reach Neuro offers products and services including Spinal Cord Stimulation and Electrode Array. Reach Neuro operates in a competitive market with competitors including Conformal Medical, Perfuze, MIVI Neuroscience, MicroTransponder and Wallaby Medical, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reach Neuro, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$880 K (USD)
in 2 rounds
-
Latest Funding Round
$680 K (USD), Seed
Dec 22, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reach Neuro
Reach Neuro offers a comprehensive portfolio of products and services, including Spinal Cord Stimulation and Electrode Array.
Implanted system to restore arm and hand movement in stroke patients via electrical pulses.
Device targeting spinal cord for precise movement restoration in neurological disorders.
Funding Insights of Reach Neuro
Reach Neuro has successfully raised a total of $880K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $680 thousand completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Reach Neuro
Reach Neuro has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked |
Investor details for Reach Neuro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reach Neuro
Investment portfolio details for Reach Neuro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reach Neuro
Detailed financials for Reach Neuro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reach Neuro Comparisons
Peer comparison for Reach Neuro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reach Neuro
Reach Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, Perfuze, MIVI Neuroscience, MicroTransponder and Wallaby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stroke prevention device for atrial fibrillation patients is developed.
|
|
| Locked | Locked | Locked |
A medical device for acute ischemic stroke treatment is developed.
|
|
| Locked | Locked | Locked |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
Neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation
|
|
| Locked | Locked | Locked |
A medical device for stroke treatment is developed.
|
|
| Locked | Locked | Locked |
Stroke recovery therapy is developed via deep brain stimulation.
|
Detailed competitors of Reach Neuro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reach Neuro
Complete news archive for Reach Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reach Neuro
Reach Neuro was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Reach Neuro is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Marc Powell is the current CEO of Reach Neuro.
Reach Neuro is a funded company, having raised a total of $880K across 2 funding rounds to date.
Reach Neuro was founded in 2018 in Pittsburgh, United States, within the medical device sector focused on neurotechnology. A simulation device is provided for chronic stroke treatment, where neural circuits in the spinal cord are reactivated to generate movement. Brain damage from stroke is addressed, and functionality in arms and hands is restored for patients through these operations.
Reach Neuro's top competitors include MicroTransponder, Perfuze and Conformal Medical.
Reach Neuro offers Spinal Cord Stimulation and Electrode Array.
Reach Neuro has 1 investor. Key investors include IndieBio.